Sickle cell anemia, caused by a single point mutation in normal adult hemoglobin A, is a common and devastating genetic disorder. It causes damage when normal disc-shaped, flexible red blood cells (RBCs) get exposed to low levels of oxygen. The hemoglobin can then bind abnormally and pull the RBC into a stiff, crescent shape.

Sickled RBCs cannot squish through narrow capillary beds, further impeding blood flow and oxygenation, resulting in more sickling and hypoxia.
The kidney as a target of this disease has been recognized for decades. Virtually all patients with the disease (HbSS) and many carriers who are generally asymptomatic (HbAS) cannot concentrate their urine appropriately. The medulla of the kidney must be able to generate an osmotic gradient for water to be fully conserved. However, oxygen tension in this portion of the kidney is normally low, promoting sickling even in HbAS patients. This damages the medulla. Urine osmolality cannot be greater than blood, so specific gravity on the urinalysis is <1.010.
Chronic kidney disease (CKD) is now recognized as a major long-term complication of this disorder, with the risk of CKD being three times higher in these patients than the general population. The pathogenesis of this CKD is poorly understood, and we really can’t diagnose it until it happens. Two abstracts I visited examined aspects of sickle cell nephropathy.
E556 749.4 Plasma Soluble Urokinase-type Plasminogen
Activator Receptor (suPAR) as an Early Indicator of Sickle Cell
Disease-Associated Chronic Kidney Disease. N. Afangbedji, A.
Taye, N. Smith, X. Niu, J.G. Taylor, S. Nekhai, M. Jerebtsova.
Howard University.
These investigators looked at a marker of CKD progression in focal sclerosis, soluble urokinase-type plasminogen activator receptor (suPAR). Their analysis included 30 patients with CKD stage 1-4 and 14 age-matched controls with no evidence of kidney problems. The patients averaged 41-years-old. CKD increased with age, but no gender differences were noted. Plasma suPAR increased with CKD stage across the population, with the distribution of levels looking identical in the unaffected and CKD1 groups.
This is a small cross-sectional study, so it is unclear if suPAR will prove to be a predictor of sickle cell nephropathy or merely another marker of worsening kidney disease. Only larger, longitudinal studies can make that happen.
D55 864.5 Glomerular hyperfiltration predicts the onset
of chronic kidney disease in humanized sickle cell mice. M.
Kasztan, J.S. Speed, D.M. Pollock.
Birmingham and
This group used a humanized HbSS mouse model to examine kidney phenotype. They examined
A clinician at their institution has shown that hyperfiltration (estimated GFR using cystatin C > 180 mL/minute/1.73m^2) predicts the development of albuminuria over the following 10 years in a small patient population, suggesting that these data may be important for
Having an animal model can allow us to tease out factors contributing to sickle cell nephropathy that we can’t study easily in people. I look forward to seeing what comes out of this model in the future, and how it will impact patients with HbSS.









